These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 35170168)
41. [Problems in diagnosis of Barber's type of pustular psoriasis]. CERUTTI P Soc Ital Dermatol Sifilogr Sezioni Interprov Soc Ital Dermatol Sifilogr; 1955; (1):75-7. PubMed ID: 13341749 [No Abstract] [Full Text] [Related]
42. Combination therapy with biologic and colchicine for generalized pustular psoriasis. Taguchi R; Takamura S; Teraki Y Int J Dermatol; 2020 Nov; 59(11):e400-e402. PubMed ID: 32492187 [No Abstract] [Full Text] [Related]
43. Reactivation of pustular psoriasis following mRNA vaccination versus COVID-19 infection: An overlap?: Reply to "Generalized pustular psoriasis following COVID-19" by Dadras MS et al.: Reply to "Generalized pustular psoriasis following COVID-19" by Dadras MS et al. Almeida RO; Hanemann T; Peres FLX; Escobar GF; Rangel Bonamigo R Dermatol Ther; 2022 Dec; 35(12):e15892. PubMed ID: 36193726 [No Abstract] [Full Text] [Related]
45. Management of pediatric generalized pustular psoriasis using biologics: An evidence-based review. Sachdeva M; Rankin BD; Mufti A; Yeung J; Vender R; Luca NJ; Miettunen P; Stevenson R; Devani AR; Prajapati VH J Am Acad Dermatol; 2022 Aug; 87(2):484-486. PubMed ID: 34695531 [No Abstract] [Full Text] [Related]
46. It Is Time to Focus on Pustular Psoriasis. Cowen EW JAMA Dermatol; 2022 Jan; 158(1):13-14. PubMed ID: 34878490 [No Abstract] [Full Text] [Related]
47. Adalimumab treatment for acrodermatitis continua of Hallopeau: three cases refractory to IL-17 inhibition. Zhang Z; Wu X; Han C; Chen M; Liu Y J Dtsch Dermatol Ges; 2023 Jul; 21(7):785-787. PubMed ID: 37186059 [No Abstract] [Full Text] [Related]
48. Effectiveness and safety profile of secukinumab for the treatment of patients with generalized pustular psoriasis in daily practice. Reymundo A; Vilarrasa E; Baniandrés O; Rodríguez-Fernández-Freire L; Feltes R; Llamas-Velasco M; Daudén E J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):e849-e851. PubMed ID: 35689497 [No Abstract] [Full Text] [Related]
54. Acrodermatitis continua of Hallopeau in an elderly patient successfully and rapidly treated with risankizumab: a case report. Orsini D; Iacovelli P; Frascione P; Pacifico A J Dermatolog Treat; 2023 Dec; 34(1):2229468. PubMed ID: 37381703 [No Abstract] [Full Text] [Related]
58. [Impetigo herpetiformis; acrodermatitis continua of Hallopeau and pustular psoriasis; etiology and pathogenesis and differential diagnosis]. GRANELLI U Minerva Dermatol; 1956 Apr; 31(4):120-6. PubMed ID: 13348185 [No Abstract] [Full Text] [Related]
59. A case of pediatric psoriasis successfully and rapidly treated with ixekizumab. Megna M; Fornaro L; De Lucia M; Rescigno O; Camela E; Fabbrocini G Dermatol Ther; 2021 Nov; 34(6):e15108. PubMed ID: 34427377 [No Abstract] [Full Text] [Related]
60. Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3). Menter A; Warren RB; Langley RG; Merola JF; Kerr LN; Dennehy EB; Shrom D; Amato D; Okubo Y; Reich K J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1686-1692. PubMed ID: 28322474 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]